Sunil Jaiswal

Title: Sunil Jaiswal: Innovator in Pharmaceutical Composition

Introduction

Sunil Jaiswal is a notable inventor based in Vadodara, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable compositions for medications. With a total of 2 patents to his name, Jaiswal's work is recognized for its innovative approach to drug formulation.

Latest Patents

One of his latest patents is focused on a pharmaceutical composition comprising fingolimod and a weak acid cation exchange resin in the form of an ion-exchange complex. This invention aims to enhance the stability and efficacy of fingolimod, a drug used in the treatment of multiple sclerosis. The composition also includes pharmaceutically acceptable excipients, which are crucial for the formulation's effectiveness.

Career Highlights

Sunil Jaiswal is currently associated with Sun Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Sun Pharmaceutical has allowed him to contribute to the development of innovative drug formulations that address critical health issues.

Collaborations

Throughout his career, Jaiswal has collaborated with talented professionals such as Krishna Sharma and Nitin Bhalachandra Dharmadhikari. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in pharmaceutical research.

Conclusion

Sunil Jaiswal's contributions to pharmaceutical innovations, particularly in the formulation of stable compositions, highlight his role as a key inventor in the industry. His work continues to impact the field positively, paving the way for future advancements in medication development.